[go: up one dir, main page]

AU2019902672A0 - Methods of treatment - Google Patents

Methods of treatment

Info

Publication number
AU2019902672A0
AU2019902672A0 AU2019902672A AU2019902672A AU2019902672A0 AU 2019902672 A0 AU2019902672 A0 AU 2019902672A0 AU 2019902672 A AU2019902672 A AU 2019902672A AU 2019902672 A AU2019902672 A AU 2019902672A AU 2019902672 A0 AU2019902672 A0 AU 2019902672A0
Authority
AU
Australia
Prior art keywords
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019902672A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosceptre (uk) Ltd
Original Assignee
Biosceptre (uk) Ltd
Filing date
Publication date
Application filed by Biosceptre (uk) Ltd filed Critical Biosceptre (uk) Ltd
Publication of AU2019902672A0 publication Critical patent/AU2019902672A0/en
Priority to JP2022505386A priority Critical patent/JP2022541344A/en
Priority to PCT/GB2020/051791 priority patent/WO2021019222A1/en
Priority to BR112022000142A priority patent/BR112022000142A2/en
Priority to EP20754010.5A priority patent/EP4003531A1/en
Priority to AU2020319701A priority patent/AU2020319701A1/en
Priority to US17/618,849 priority patent/US20220251187A1/en
Priority to CA3143419A priority patent/CA3143419A1/en
Priority to CN202080053631.3A priority patent/CN114173811A/en
Priority to MX2021015593A priority patent/MX2021015593A/en
Abandoned legal-status Critical Current

Links

AU2019902672A 2019-07-26 2019-07-26 Methods of treatment Abandoned AU2019902672A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2022505386A JP2022541344A (en) 2019-07-26 2020-07-24 Targeted therapy for P2X7 receptors
PCT/GB2020/051791 WO2021019222A1 (en) 2019-07-26 2020-07-24 P2x7 receptor targeted therapy
BR112022000142A BR112022000142A2 (en) 2019-07-26 2020-07-24 treatment methods
EP20754010.5A EP4003531A1 (en) 2019-07-26 2020-07-24 P2x7 receptor targeted therapy
AU2020319701A AU2020319701A1 (en) 2019-07-26 2020-07-24 P2X7 receptor targeted therapy
US17/618,849 US20220251187A1 (en) 2019-07-26 2020-07-24 P2x7 receptor targeted therapy
CA3143419A CA3143419A1 (en) 2019-07-26 2020-07-24 P2x7 receptor targeted therapy
CN202080053631.3A CN114173811A (en) 2019-07-26 2020-07-24 P2X7 receptor targeted therapy
MX2021015593A MX2021015593A (en) 2019-07-26 2020-07-24 P2x7 receptor targeted therapy.

Publications (1)

Publication Number Publication Date
AU2019902672A0 true AU2019902672A0 (en) 2019-08-08

Family

ID=

Similar Documents

Publication Publication Date Title
EP3684342A4 (en) Method of treatment
EP4017493A4 (en) Methods of treatment using bcn057 and bcn512
EP3856241A4 (en) Treatment methods
EP3890780A4 (en) Method of treatment
GB201918853D0 (en) Methods of treatment
HK40075476A (en) Methods of treatment
AU2019903451A0 (en) Methods of treatment
AU2019902672A0 (en) Methods of treatment
EP4034125A4 (en) Treatment of excitotoxicity-related conditions
AU2019903303A0 (en) Method of Treatment
AU2019901742A0 (en) Method of treatment
AU2019901280A0 (en) Method of Treatment
HK40062182A (en) Method of treatment
AU2019903588A0 (en) Treatment of excitotoxicity-related conditions
AU2019900339A0 (en) Method of Treatment
AU2018904581A0 (en) Method of treatment
IL290983A (en) Methods of treatment
AU2018901775A0 (en) Method of treatment
HK40067839A (en) Methods of treatment using omalizumab
HK40077844A (en) Treatment of tauopathies
HK40104531A (en) Methods of treatment
HK40032171A (en) Combination treatment of sarcoglycanopathies
AU2019900337A0 (en) Treatment Methods
AU2021903030A0 (en) Methods of treatment
AU2021902512A0 (en) Methods of treatment